The Concise Guide to PHARMACOLOGY 2015/16: Transporters

The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands ( www.guidetopharmacology.org ), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13355/full . G protein‐coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ligand‐gated ion channels, voltage‐gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets. It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org , superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOLOGY 2013/14. It is produced in conjunction with NC‐IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR‐DB and GRAC and provides a permanent, citable, point‐in‐time record that will survive database updates.

[1]  G. Hajnóczky,et al.  The mitochondrial phosphate carrier: Role in oxidative metabolism, calcium handling and mitochondrial disease. , 2015, Biochemical and biophysical research communications.

[2]  S. Alper,et al.  K-Cl cotransporters, cell volume homeostasis, and neurological disease. , 2015, Trends in molecular medicine.

[3]  L. Matherly,et al.  Structural determinants of human proton-coupled folate transporter oligomerization: role of GXXXG motifs and identification of oligomeric interfaces at transmembrane domains 3 and 6. , 2015, The Biochemical journal.

[4]  T. Kambe,et al.  The Physiological, Biochemical, and Molecular Roles of Zinc Transporters in Zinc Homeostasis and Metabolism. , 2015, Physiological reviews.

[5]  M. Wessling-Resnick Nramp1 and Other Transporters Involved in Metal Withholding during Infection* , 2015, The Journal of Biological Chemistry.

[6]  T. Moos,et al.  Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology , 2015, Front. Mol. Neurosci..

[7]  F. Codazzi,et al.  Iron entry in neurons and astrocytes: a link with synaptic activity , 2015, Front. Mol. Neurosci..

[8]  M. D. Parker,et al.  Na+–H+ exchanger-1 (NHE1) regulation in kidney proximal tubule , 2015, Cellular and Molecular Life Sciences.

[9]  M. Inazu Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy. , 2014, Biopharmaceutics & drug disposition.

[10]  D. Bertrand,et al.  Zinc: an underappreciated modulatory factor of brain function. , 2014, Biochemical pharmacology.

[11]  F. Palmieri Mitochondrial transporters of the SLC25 family and associated diseases: a review , 2014, Journal of Inherited Metabolic Disease.

[12]  Ayako Hashimoto,et al.  Current understanding of ZIP and ZnT zinc transporters in human health and diseases , 2014, Cellular and Molecular Life Sciences.

[13]  W. Boron,et al.  Intracellular pH regulation by acid-base transporters in mammalian neurons , 2014, Front. Physiol..

[14]  M. Adams,et al.  Phosphate: an old bone molecule but new cardiovascular risk factor , 2014, British journal of clinical pharmacology.

[15]  W. Hellstrom,et al.  J Urol , 2014 .

[16]  B. Gasnier,et al.  Vesicular neurotransmitter transporters: mechanistic aspects. , 2014, Current topics in membranes.

[17]  M. Monné,et al.  Antiporters of the mitochondrial carrier family. , 2014, Current topics in membranes.

[18]  Bruno Stieger,et al.  Organic anion-transporting polypeptides. , 2014, Current topics in membranes.

[19]  H. Castrop,et al.  Physiology and pathophysiology of the renal NaK-2 Cl cotransporter ( NKCC 2 ) , 2014 .

[20]  Helle H Damkier,et al.  Na+ dependent acid-base transporters in the choroid plexus; insights from slc4 and slc9 gene deletion studies , 2013, Front. Physiol..

[21]  K. Borges Slc10A4 — what do we know about the function of this “secret ligand carrier” protein? , 2013, Experimental Neurology.

[22]  C. Baines,et al.  Physiological and pathological roles of mitochondrial SLC25 carriers. , 2013, The Biochemical journal.

[23]  L. Agellon,et al.  Transport and biological activities of bile acids. , 2013, The international journal of biochemistry & cell biology.

[24]  Fabian Müller,et al.  Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects , 2013, Pharmacological Reviews.

[25]  W. Löscher,et al.  Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments , 2013, Neuropharmacology.

[26]  E. Delpire,et al.  Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts. , 2013, American journal of physiology. Cell physiology.

[27]  H. Murer,et al.  Phosphate transporters of the SLC20 and SLC34 families. , 2013, Molecular aspects of medicine.

[28]  D. Krantz,et al.  SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. , 2013, Molecular aspects of medicine.

[29]  F. Palmieri The mitochondrial transporter family SLC25: identification, properties and physiopathology. , 2013, Molecular aspects of medicine.

[30]  M. Hediger,et al.  Zinc transporters in prostate cancer. , 2013, Molecular aspects of medicine.

[31]  B. Clémençon,et al.  The mitochondrial ADP/ATP carrier (SLC25 family): pathological implications of its dysfunction. , 2013, Molecular aspects of medicine.

[32]  H. Schiöth,et al.  Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects. , 2013, Molecular aspects of medicine.

[33]  D. Eide,et al.  The SLC39 family of zinc transporters. , 2013, Molecular aspects of medicine.

[34]  J. Polli,et al.  The solute carrier family 10 (SLC10): beyond bile acid transport. , 2013, Molecular aspects of medicine.

[35]  M. Hediger,et al.  Mammalian iron transporters: families SLC11 and SLC40. , 2013, Molecular aspects of medicine.

[36]  Bruno Stieger,et al.  The SLCO (former SLC21) superfamily of transporters. , 2013, Molecular aspects of medicine.

[37]  B. Kolisnyk,et al.  Regulation of cholinergic activity by the vesicular acetylcholine transporter. , 2013, The Biochemical journal.

[38]  Kazuya Maeda,et al.  Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. , 2013, Biopharmaceutics & drug disposition.

[39]  S. Bröer The SLC38 family of sodium–amino acid co-transporters , 2013, Pflügers Archiv - European Journal of Physiology.

[40]  D. Khananshvili Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific and systemic functions , 2013, Pflügers Archiv - European Journal of Physiology.

[41]  M. Anwer,et al.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters , 2013, Pflügers Archiv - European Journal of Physiology.

[42]  R. Kim,et al.  Impact of genetic variation in OATP transporters to drug disposition and response. , 2013, Drug metabolism and pharmacokinetics.

[43]  B. Hagenbuch,et al.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies , 2012, British journal of pharmacology.

[44]  Bruno Hagenbuch,et al.  The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. , 2012, Annual review of pharmacology and toxicology.

[45]  K. Wimalasena Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistry , 2011, Medicinal research reviews.

[46]  S. Bröer,et al.  The role of amino acid transporters in inherited and acquired diseases. , 2011, The Biochemical journal.

[47]  R. Fredriksson,et al.  Identification of SLC38A7 (SNAT7) Protein as a Glutamine Transporter Expressed in Neurons* , 2011, The Journal of Biological Chemistry.

[48]  S. V. van IJzendoorn,et al.  Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions. , 2011, Biochemistry.

[49]  T. Shippenberg,et al.  Regulation of monoamine transporters: Role of transporter phosphorylation. , 2011, Pharmacology & therapeutics.

[50]  L. Eiden,et al.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse , 2011, Annals of the New York Academy of Sciences.

[51]  R. Lifton,et al.  Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases. , 2010, Biochimica et biophysica acta.

[52]  M. Kassiou,et al.  PET radioligands for the vesicular acetylcholine transporter (VAChT). , 2010, Current Topics in Medicinal Chemistry.

[53]  J. Rungby Zinc, zinc transporters and diabetes , 2010, Diabetologia.

[54]  F. Thévenod Catch me if you can! Novel aspects of cadmium transport in mammalian cells , 2010, BioMetals.

[55]  S. Parsons,et al.  Equilibrium binding and transport by vesicular acetylcholine transporter. , 2010, Methods in molecular biology.

[56]  렁 돈미엔느든문,et al.  Anti-ferroportin 1 monoclonal antibodies and uses thereof , 2009 .

[57]  L. Siculella,et al.  The mitochondrial citrate carrier: Metabolic role and regulation of its activity and expression , 2009, IUBMB life.

[58]  S. Himeno,et al.  The role of zinc transporters in cadmium and manganese transport in mammalian cells. , 2009, Biochimie.

[59]  A. Lombardi,et al.  Uncoupling proteins: A complex journey to function discovery , 2009, BioFactors.

[60]  P. A. Friedman,et al.  Thick ascending limb: the Na+:K+:2Cl− co-transporter, NKCC2, and the calcium-sensing receptor, CaSR , 2009, Pflügers Archiv - European Journal of Physiology.

[61]  L. Fliegel,et al.  Structure and function of the human Na+/H+ exchanger isoform 1 , 2008, Channels.

[62]  Homan Kang,et al.  Dihydroxylation of olefins catalyzed by polystyrene-sg-imidazolium resin-supported osmium complex , 2008 .

[63]  B. Sundberg,et al.  The Evolutionary History and Tissue Mapping of Amino Acid Transporters Belonging to Solute Carrier Families SLC32, SLC36, and SLC38 , 2008, Journal of Molecular Neuroscience.

[64]  F. Fonnum,et al.  Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. , 2008, Annual review of pharmacology and toxicology.

[65]  Klaus Geyer Syntactic Language Change in a German Dialect: Replacement or Reanalysis of a Construction? , 2008 .

[66]  M. Knipper,et al.  Functional significance of channels and transporters expressed in the inner ear and kidney. , 2007, American journal of physiology. Cell physiology.

[67]  J. Lytton REVIEW ARTICLE Na + /Ca 2+ exchangers: three mammalian gene families control Ca 2+ transport , 2007 .

[68]  Jason A. Dunlop,et al.  Embrik Strand’s eurypterids , 2006 .

[69]  N. Nelson,et al.  The NRAMP family of metal-ion transporters. , 2006, Biochimica et biophysica acta.

[70]  D. Eide The SLC39 family of metal ion transporters , 2004, Pflügers Archiv.

[71]  B. Mackenzie,et al.  Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family , 2004, Pflügers Archiv.

[72]  Ferdinando Palmieri,et al.  The mitochondrial transporter family (SLC25): physiological and pathological implications , 2004, Pflügers Archiv.

[73]  D. Mount,et al.  Molecular physiology of cation-coupled Cl− cotransport: the SLC12 family , 2004, Pflügers Archiv.

[74]  B. Quednau,et al.  The sodium/calcium exchanger family—SLC8 , 2004, Pflügers Archiv.

[75]  Thomas D. Wu,et al.  Compositions and methods for the diagnosis and treatment of a tumor , 2000 .

[76]  H. Nakanishi,et al.  On the bioactive conformation of the gaba uptake inhibitor SK&F 89976-A , 1996 .

[77]  Peter Oelkers,et al.  Bile acid transporters , 1995, Current opinion in lipidology.